Position in PFE
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$90,521,888
-$128,251,603 QoQ
Shares Held
3,223,714
-63.3% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. PFE ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,521,888 | 3,223,714 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $218,773,491 | 8,786,084 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $33,044,883 | 1,296,895 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,293,809 | 713,441 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $18,811,529 | 742,365 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,424,096 | 958,315 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,350,614 | 530,429 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,768,655 | 527,829 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,988,856 | 576,175 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $22,470,305 | 780,490 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,205,220 | 548,846 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $115,184,625 | 3,140,257 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $146,030,216 | 3,579,172 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $180,585,745 | 3,524,312 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $159,652,627 | 3,648,369 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $174,752,176 | 3,333,057 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $231,508,293 | 4,471,862 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $58,079,040 | 983,557 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,787,572 | 739,074 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $37,526,088 | 958,276 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $153,780,191 | 4,244,554 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $168,624,217 | 4,580,935 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $185,558,650 | 5,056,099 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $180,515,566 | 5,520,348 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $194,345,510 | 5,954,221 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||